ÂÜÀòÂÒÂ×

Michael Nally is currently an executive vice president and chief marketing officer at Merck & Co., Inc.

Nally has served in his current role with Merck, a leading global health care company, since January 1, 2019. He co-leads Merck’s human health business and is responsible for developing the company’s growth strategy and commercialization model. Since joining Merck in 2003, he has served as president, global vaccines; managing director, United Kingdom and Ireland; and in a variety of key management positions in strategic initiatives, commercial operations, business development and investor relations. Nally holds a master of business administration degree from Harvard Business School, a degree in accounting and finance from the London School of Economics, and a bachelor of arts degree in economics from Middlebury College. He also previously served as director of Hilleman Laboratories, a non-profit vaccine research firm located in India.